vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and USA Compression Partners, LP (USAC). Click either name above to swap in a different company.

USA Compression Partners, LP is the larger business by last-quarter revenue ($252.5M vs $164.7M, roughly 1.5× PTC THERAPEUTICS, INC.). USA Compression Partners, LP runs the higher net margin — 11.0% vs -82.0%, a 93.0% gap on every dollar of revenue. On growth, USA Compression Partners, LP posted the faster year-over-year revenue change (2.7% vs -22.7%). USA Compression Partners, LP produced more free cash flow last quarter ($87.7M vs $-36.6M). Over the past eight quarters, USA Compression Partners, LP's revenue compounded faster (4.9% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

PTCT vs USAC — Head-to-Head

Bigger by revenue
USAC
USAC
1.5× larger
USAC
$252.5M
$164.7M
PTCT
Growing faster (revenue YoY)
USAC
USAC
+25.4% gap
USAC
2.7%
-22.7%
PTCT
Higher net margin
USAC
USAC
93.0% more per $
USAC
11.0%
-82.0%
PTCT
More free cash flow
USAC
USAC
$124.4M more FCF
USAC
$87.7M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
USAC
USAC
Annualised
USAC
4.9%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PTCT
PTCT
USAC
USAC
Revenue
$164.7M
$252.5M
Net Profit
$-135.0M
$27.8M
Gross Margin
Operating Margin
-43.3%
30.3%
Net Margin
-82.0%
11.0%
Revenue YoY
-22.7%
2.7%
Net Profit YoY
-104.8%
9.1%
EPS (diluted)
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
USAC
USAC
Q4 25
$164.7M
$252.5M
Q3 25
$211.0M
$250.3M
Q2 25
$178.9M
$250.1M
Q1 25
$1.2B
$245.2M
Q4 24
$213.2M
$245.9M
Q3 24
$196.8M
$240.0M
Q2 24
$186.7M
$235.3M
Q1 24
$210.1M
$229.3M
Net Profit
PTCT
PTCT
USAC
USAC
Q4 25
$-135.0M
$27.8M
Q3 25
$15.9M
$34.5M
Q2 25
$-64.8M
$28.6M
Q1 25
$866.6M
$20.5M
Q4 24
$-65.9M
$25.4M
Q3 24
$-106.7M
$19.3M
Q2 24
$-99.2M
$31.2M
Q1 24
$-91.6M
$23.6M
Operating Margin
PTCT
PTCT
USAC
USAC
Q4 25
-43.3%
30.3%
Q3 25
1.4%
33.5%
Q2 25
-19.5%
30.6%
Q1 25
82.5%
28.3%
Q4 24
-76.2%
30.3%
Q3 24
-27.7%
31.5%
Q2 24
-21.5%
32.9%
Q1 24
-21.6%
29.2%
Net Margin
PTCT
PTCT
USAC
USAC
Q4 25
-82.0%
11.0%
Q3 25
7.5%
13.8%
Q2 25
-36.3%
11.4%
Q1 25
73.7%
8.4%
Q4 24
-30.9%
10.3%
Q3 24
-54.2%
8.1%
Q2 24
-53.1%
13.3%
Q1 24
-43.6%
10.3%
EPS (diluted)
PTCT
PTCT
USAC
USAC
Q4 25
$-1.63
Q3 25
$0.20
Q2 25
$-0.83
Q1 25
$10.04
Q4 24
$-0.85
Q3 24
$-1.39
Q2 24
$-1.29
Q1 24
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
USAC
USAC
Cash + ST InvestmentsLiquidity on hand
$1.9B
$8.6M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$-205.3M
Total Assets
$2.9B
$2.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
USAC
USAC
Q4 25
$1.9B
$8.6M
Q3 25
$1.7B
Q2 25
$2.0B
$2.0K
Q1 25
$2.0B
$2.0K
Q4 24
$1.1B
$14.0K
Q3 24
$1.0B
$79.0K
Q2 24
$1.1B
$9.0K
Q1 24
$884.8M
$8.0K
Total Debt
PTCT
PTCT
USAC
USAC
Q4 25
$2.5B
Q3 25
$2.5B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.5B
Q2 24
$2.5B
Q1 24
$2.5B
Stockholders' Equity
PTCT
PTCT
USAC
USAC
Q4 25
$-205.3M
Q3 25
$-155.8M
Q2 25
$-206.5M
Q1 25
$-185.8M
Q4 24
$-1.1B
Q3 24
$-1.1B
Q2 24
$-980.2M
Q1 24
$-893.9M
Total Assets
PTCT
PTCT
USAC
USAC
Q4 25
$2.9B
$2.6B
Q3 25
$2.6B
$2.7B
Q2 25
$2.6B
$2.7B
Q1 25
$2.7B
$2.7B
Q4 24
$1.7B
$2.7B
Q3 24
$1.8B
$2.8B
Q2 24
$1.9B
$2.8B
Q1 24
$1.8B
$2.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
USAC
USAC
Operating Cash FlowLast quarter
$-34.3M
$139.5M
Free Cash FlowOCF − Capex
$-36.6M
$87.7M
FCF MarginFCF / Revenue
-22.3%
34.8%
Capex IntensityCapex / Revenue
1.4%
20.5%
Cash ConversionOCF / Net Profit
5.02×
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$277.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
USAC
USAC
Q4 25
$-34.3M
$139.5M
Q3 25
$-66.3M
$75.9M
Q2 25
$-58.3M
$124.2M
Q1 25
$870.1M
$54.7M
Q4 24
$-30.0M
$130.2M
Q3 24
$-77.0M
$48.5M
Q2 24
$-71.5M
$96.7M
Q1 24
$70.8M
$65.9M
Free Cash Flow
PTCT
PTCT
USAC
USAC
Q4 25
$-36.6M
$87.7M
Q3 25
$-69.7M
$51.9M
Q2 25
$-59.6M
$101.1M
Q1 25
$868.4M
$36.3M
Q4 24
$-33.8M
$101.2M
Q3 24
$-77.5M
$19.8M
Q2 24
$-78.8M
$48.2M
Q1 24
$61.2M
$-32.7M
FCF Margin
PTCT
PTCT
USAC
USAC
Q4 25
-22.3%
34.8%
Q3 25
-33.1%
20.7%
Q2 25
-33.3%
40.4%
Q1 25
73.8%
14.8%
Q4 24
-15.8%
41.1%
Q3 24
-39.4%
8.2%
Q2 24
-42.2%
20.5%
Q1 24
29.1%
-14.3%
Capex Intensity
PTCT
PTCT
USAC
USAC
Q4 25
1.4%
20.5%
Q3 25
1.6%
9.6%
Q2 25
0.7%
9.3%
Q1 25
0.1%
7.5%
Q4 24
1.8%
11.8%
Q3 24
0.3%
12.0%
Q2 24
4.0%
20.6%
Q1 24
4.6%
43.0%
Cash Conversion
PTCT
PTCT
USAC
USAC
Q4 25
5.02×
Q3 25
-4.17×
2.20×
Q2 25
4.35×
Q1 25
1.00×
2.66×
Q4 24
5.12×
Q3 24
2.51×
Q2 24
3.10×
Q1 24
2.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

Related Comparisons